You are here

  • Home
  • Archive
  • Volume 10, Issue 2
  • PERFECTRA: a pragmatic, multicentre, real-life study comparing treat-to-target strategies with baricitinib versus TNF inhibitors in patients with active rheumatoid arthritis after failure on csDMARDs

Citation Tools

Article menu

Download PDFPDF

Rheumatoid arthritis
Original research
PERFECTRA: a pragmatic, multicentre, real-life study comparing treat-to-target strategies with baricitinib versus TNF inhibitors in patients with active rheumatoid arthritis after failure on csDMARDs

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
van de Laar CJ, Oude Voshaar MAH, ten Klooster P, et al
PERFECTRA: a pragmatic, multicentre, real-life study comparing treat-to-target strategies with baricitinib versus TNF inhibitors in patients with active rheumatoid arthritis after failure on csDMARDs
RMD Open 2024;10:e004291. doi: 10.1136/rmdopen-2024-004291